JCN Newswire Read More Eisai Presents New Data on the Relationship Between Clinical, Biomarker and Safety Outcomes from the Lecanemab Phase 2B Study ruth 4 11 月 2 minutes TOKYO, Nov 4, 2021 – (JC […]
JCN Newswire Read More Notice Regarding Biogen’s Disclosure About the Submission of Marketing Authorization Applications in Brazil, Canada, Australia, and Switzerland for Aducanumab for Alzheimer’s Disease ruth 23 4 月 1 minute TOKYO, Apr 23, 2021 – (J […]
